General Psychiatry and Psychology (Adult)
Showing 1-20 of 24 Results
-
Maryam S. Makowski, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioMaryam S. Makowski, PhD, FACN, CNS, NBC-HWC, is a Clinical Associate Professor in the Stanford University Department of Psychiatry and Behavioral Sciences and the Associate Director of Scholarship and Health Promotion for Stanford Medicine’s WellMD & WellPhD. As a medical nutrition scientist, Certified Nutrition Specialist, and National Board Certified Health and Wellness Coach, Dr. Makowski provides nutrition consultations and well-being coaching to Stanford School of Medicine faculty, as well as Stanford Medicine residents and fellows through the WellConnect Program. She also serves patients of the Lifestyle Psychiatry Clinic and provides group nutrition coaching and education to Geriatric Psychiatry patients within the Department of Psychiatry and Behavioral Sciences. Dr.Makowski is a member of the Well-Being Advisory Committee in the Department of Psychiatry and Behavioral Sciences.
Dr. Makowski's research focuses on identifying nutritional strategies to minimize physician fatigue, stress, and sleep-related impairment. In her coaching, she employs evidence-based strategies to optimize the well-being and performance of her clients. She has delivered over 100 lectures, grand rounds, seminars, and webinars to thousands of physicians and physician trainees worldwide.
In her coaching, Dr. Makowski incorporates a Whole Person Health approach by addressing the interconnected dimensions of physical, mental, emotional, and social well-being, empowering clients to achieve a balanced and fulfilling life through personalized strategies and holistic support. In recognition of her contributions, she received the 2024 Annual Chairman's Award for Clinical Innovation and Service in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
She earned her master's and doctoral degrees in clinical nutrition, nutritional epidemiology, and medical science from the University of Toronto. Prior to joining Stanford, Dr. Makowski worked as a scientific associate at Toronto General Hospital-University Health Network and served as an advisor to Air Canada rouge pilots and cabin crew on fatigue management. Throughout her career, she has authored highly cited scientific papers related to nutrition and well-being, making significant contributions to the field. -
Alan G. Maloney
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioPsychiatrist and Jungian Analyst in private practice in San Francisco and Palo Alto.
-
Rachel Manber, PhD
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
Current Research and Scholarly InterestsRecent and current projects include
Treatment of insomnia during pregnancy
Treatment of insomnia comorbid with sleep apnea
Use of digital interventions for insomnia among middle age and older adults
Mobile intervention for insomnia among those with alcohol use -
Jessie Markovits, MD
Clinical Associate Professor, Medicine
Clinical Associate Professor (By courtesy), Psychiatry and Behavioral SciencesCurrent Research and Scholarly InterestsHypnosis for perioperative symptom management in elective orthopedic surgery.
-
Brittany Elizabeth Matheson, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioBrittany Matheson, PhD, is a clinical assistant professor and licensed clinical psychologist in the Eating Disorders Clinic. She completed her undergraduate degree at Duke University, doctorate from the Joint Doctoral Program in Clinical Psychology at San Diego State University and the University of California, San Diego, and APA clinical internship at Lucile Packard Children’s Hospital Stanford (LPCH)/Children’s Health Council. Dr. Matheson is a certified family-based treatment (FBT) therapist and consultant. She is also the director of the Stanford Eating Disorder Research Program Data Coordination Center and collaborates with colleagues on NIH-funded randomized clinical trials. Dr. Matheson's research interests include examining the psychosocial, neurocognitive, and familial factors related to disordered eating and excess weight gain in youth. She is interested in the development and implementation of evidence-based treatments for youth with disordered eating as well as better understanding factors that influence pediatric bariatric surgery outcomes. Dr. Matheson has specialized research and clinical expertise in the interplay among obesity, disordered eating, and autism spectrum disorder and is the director of psychological services for the LPCH adolescent metabolic and bariatric surgery program. She conducts comprehensive evaluations and provides evidence-based treatments for individuals across the age-spectrum with eating disorders, including anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant/restrictive food intake disorder, and other specified feeding and eating disorders. Her recent research focuses on reducing access to care barriers by digitizing evidence-based treatments and utilizing technology to enhance treatment outcomes.
-
Carmen McLean
Clinical Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
BioCarmen McLean, PhD, is a clinical psychologist and researcher with the Dissemination and Training Division of the National Center for PTSD at the Palo Alto VA Health Care System. Dr. McLean’s research focuses on increasing the implementation and reach of evidence-based treatments for posttraumatic stress disorder (PTSD).
-
M Windy McNerney, PhD
Clinical Associate Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. M. Windy McNerney is the Director of Biological Sciences for the MIRECC at the Department of Veterans Affairs in Palo Alto, and a Clinical Associate Professor (Affiliated) at Psychiatry and Behavioral Sciences at Stanford School of Medicine. Dr. McNerney holds a particular passion for not only understanding the neurophysiology and biochemistry of mental health diseases, but also advocating for these invisible diseases. Her research focuses on neurodegeneration, depression, TBI, PTSD, and addiction. She is collaborating with researchers to integrate brain imaging and biochemical markers in hopes to better understand these diseases. She also is taking a lead role at the VA in investigating the biochemistry of magnetic brain stimulation and is the leader of the NeuroNado Laboratory. At Stanford University, she is the professor of two popular courses examining the biological and societal issues surrounding substance use disorder, with a major focus on opioids such as fentanyl. She has individually mentored over 25 students from underrepresented groups in STEM activities and leads monthly seminars aimed at facilitating career development. In her free time, she is a community advocate for the treatment of mental health and educates groups about the dangers of fentanyl.
She earned her BS from UC Davis and her PhD from the University of Notre Dame. While at ND, she interned at NASA Ames on Human Factors Engineering. She then went on to a postdoctoral position at Lawrence Livermore National Laboratory (DOE), and then completed a fellowship at the WRIISC program at the VA and Stanford University.
Selected Publications:
McNerney MW, Gurkoff G, Berryhill M (2023). The rehabilitation potential of neurostimulation for mild traumatic brain injury in animal and human studies. Brain Sciences, 13, 1402.
McNerney MW, Kraybill EP Narayanan S, Mojabi F, Venkataramanan V, Heath A (2023). Memory-related hippocampal brain-derived neurotrophic factor activation pathways from repetitive transcranial magnetic stimulation in the 3xTg-AD mouse line. Experimental Gerontology, 183, 11323.
Shuken, S, McNerney MW (2023). Cost and benefits for popular p-value correction methods I three models of quantitative omic experiments. Analytical Chemistry, 95, 2732.
McNerney MW, Heath A, Narayanan S, Yesavage J (2022). Repetitive transcranial magnetic stimulation improves brain-derived neurotrophic factor and cholinergic signaling in the 3xTgAD mouse model of Alzheimer’s disease. Journal of Alzheimer’s Disease, 86, 499..
Heath AM, Brewer M, Yesavage J, McNerney MW. (2021). Improved object recognition memory using post-encoding repetitive transcranial magnetic stimulation. Brain Stimulation, 15, 78.
Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, Losada PM, Chen MB, Schaum N, Khoury N, Toland A, Calcuttawala K, Shin H, Palovics R, Shin A, Wang EY, Luo J, Gate D, Schultz-Schaeffer WJ, Chu P, Siegenthalar J, McNerney MW, Keller A, Wyss-Coray T (2022). A human brain vascular atlas reveals diverse mediators or Alzheimer’s disease. Nature, 603, 885.
McNerney MW, Hobday T, Cole B, Ganong R, Winas N, Matthews D, Hood J, Lane S (2019). Objective classification of mTBI using machine learning on a combination of frontal electroencephalography measurements and self-reported symptoms. Sports Medicine Open, 4, 14.
McNerney MW, Sheng T, Nechvatal JM, Lee A, Lyons D, Adamson M (2018). Integration of neural and epigenetic contributions to posttraumatic stress symptoms: The role of hippocampal volume and glucocorticoid receptor gene methylation. PLOSONE, e0192222.
Bennion BJ, Be NA, McNerney MW, Lao V, Carlson E, Valdez CA (2017). Predicting a drug’s membrane permeability: A computational model validated with in vitro permeability assay data. Journal of Physical Chemistry, B, 121, 5228.
See more publications at: https://www.ncbi.nlm.nih.gov/pubmed/?term=McNerney%20MW%5BAuthor%5D&cauthor=true&cauthor_uid=17107728 -
Anish Mitra
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioAnish Mitra is a neuroscientist and psychiatrist interested in understanding how neural activity in large-scale networks causes mental illness.
-
Michelle Monje
Milan Gambhir Professor of Pediatric Neuro-Oncology and Professor, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states.
